Tag Archives: MultiCell Technologies

MultiCell teams with Maxim Biotech to study live stem cells and cancer

Rhode Island-based biotechnology company MultiCell Technologies Inc. is teaming up with Maxim Biotech Inc. under cooperative research and development agreement to develop products for studying liver stem cells and liver cancer.

MultiCell (OTC: MCET), based in Woonsocket, owns exclusive rights to two issued U.S. patents, one U.S. patent application and a handful of corresponding foreign patents and patent applications regarding the isolation and differentiation of liver stem cells.

No financial details of the agreement with South San Francisco-based Maxim Biotech were disclosed. The deal will initially focus on creating a family of research reagent tool kits which can be used to
Read More…